These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33407967)

  • 41. Predictors of vasovagal syncope recurrence in children and adolescents and value of head-up tilt table test.
    Tanrıverdi Yılmaz S; Binnetoğlu K; Babaoğlu K; Altun G
    Anadolu Kardiyol Derg; 2013 Nov; 13(7):688-94. PubMed ID: 23996804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope.
    Romme JJ; Reitsma JB; Black CN; Colman N; Scholten RJ; Wieling W; Van Dijk N
    Cochrane Database Syst Rev; 2011 Oct; 2011(10):CD004194. PubMed ID: 21975744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurocardiogenic syncope: latest pharmacological therapies.
    Chen LY; Shen WK
    Expert Opin Pharmacother; 2006 Jun; 7(9):1151-62. PubMed ID: 16732702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcitonin gene-related peptide predicts therapeutic response to midodrine hydrochloride in children with vasovagal syncope.
    Li L; Zhao H; Ma X; Jiao F; Lin J
    Front Neurosci; 2022; 16():1026539. PubMed ID: 36267231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Efficacy of Empirical Therapy in Children with Vasovagal Syncope.
    Tao C; Cui Y; Zhang C; Liu X; Zhang Q; Liu P; Wang Y; Du J; Jin H
    Children (Basel); 2022 Jul; 9(7):. PubMed ID: 35884049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of postspace-flight orthostatic intolerance to vasovagal syncope and autonomic failure and the potential use of the alpha agonist midodrine for these conditions.
    Piwinski SE; Jankovic J; McElligott MA
    J Clin Pharmacol; 1994 May; 34(5):466-71. PubMed ID: 7522240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study.
    Lamarre-Cliche M; Souich Pd; Champlain Jd; Larochelle P
    Clin Ther; 2008 Sep; 30(9):1629-38. PubMed ID: 18840368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Summary for Patients: Midodrine to Prevent Fainting.
    Ann Intern Med; 2021 Oct; 174(10):I28. PubMed ID: 34339224
    [No Abstract]   [Full Text] [Related]  

  • 49. The vasovagal Syncope and pacing (Synpace) trial: rationale and study design.
    Raviele A; Giada F; Sutton R; Alboni P; Brignole M; Del Rosso A; Di Girolamo E; Luise R; Menozzi C
    Europace; 2001 Oct; 3(4):336-41. PubMed ID: 11678394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
    Sheldon R; Connolly S; Rose S; Klingenheben T; Krahn A; Morillo C; Talajic M; Ku T; Fouad-Tarazi F; Ritchie D; Koshman ML;
    Circulation; 2006 Mar; 113(9):1164-70. PubMed ID: 16505178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Putting it together: a new treatment algorithm for vasovagal syncope and related disorders.
    Bloomfield DM; Sheldon R; Grubb BP; Calkins H; Sutton R
    Am J Cardiol; 1999 Oct; 84(8A):33Q-39Q. PubMed ID: 10568559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What can I do when first-line measures are not enough for vasovagal syncope?
    Hutt Centeno E; Mayuga KA
    Cleve Clin J Med; 2018 Dec; 85(12):920-922. PubMed ID: 30526751
    [No Abstract]   [Full Text] [Related]  

  • 53. Vasovagal syncope in children and adolescents.
    Kapusta R
    Gen Dent; 2008; 56(4):340-5. PubMed ID: 19284194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Vasovagal syncope in pediatric patients: a medium-term follow-up analysis].
    Díaz JF; Tercedor L; Moreno E; García R; Alvarez M; Sánchez J; Azpitarte J
    Rev Esp Cardiol; 2002 May; 55(5):487-92. PubMed ID: 12015928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.
    Connolly SJ; Sheldon R; Thorpe KE; Roberts RS; Ellenbogen KA; Wilkoff BL; Morillo C; Gent M;
    JAMA; 2003 May; 289(17):2224-9. PubMed ID: 12734133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential risk of vasovagal syncope for motor vehicle driving.
    Li H; Weitzel M; Easley A; Barrington W; Windle J
    Am J Cardiol; 2000 Jan; 85(2):184-6. PubMed ID: 10955374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Vasovagal syncope. Management with propanthelin bromide].
    Corbalá Fuentes C; Pacheco Ureña A; Pedraza Ibarra S; Gárate Ureña JA; Manzano Miranda L; Carrillo Camacho A; Haro García L
    Arch Inst Cardiol Mex; 1997; 67(3):227-30. PubMed ID: 9412436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: a prospective and randomized study.
    Duygu H; Zoghi M; Turk U; Akyuz S; Ozerkan F; Akilli A; Erturk U; Onder R; Akin M
    Pacing Clin Electrophysiol; 2008 May; 31(5):592-6. PubMed ID: 18439174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized clinical trials of neurally mediated syncope.
    Brignole M
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S64-9. PubMed ID: 12950522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapy of vasovagal syncope (nonpharmacologic therapy and pharmacotherapy)].
    Mitro P
    Vnitr Lek; 2000 Dec; 46(12):861-8. PubMed ID: 11214367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.